# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3536232 | A | Retention time in cynomolgus monkey liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 by MS2 spectra | Macaca fascicularis | 1 | assay format | Scientific Literature | ||
2. | ALA3531176 | A | Drug level in human liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Homo sapiens | 27 | assay format | Scientific Literature | ||
3. | ALA3531177 | A | Drug level in cynomolgus monkey liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Macaca fascicularis | 27 | assay format | Scientific Literature | ||
4. | ALA3531178 | A | Drug level in beagle dog liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Canis lupus familiaris | 27 | assay format | Scientific Literature | ||
5. | ALA3531179 | A | Drug level in Sprague-Dawley rat liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Rattus norvegicus | 27 | assay format | Scientific Literature | ||
6. | ALA3531180 | A | Drug level in CD-1 mouse liver microsomes treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Mus musculus | 27 | assay format | Scientific Literature | ||
7. | ALA3531181 | A | Drug level in human liver S9 fraction treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Homo sapiens | 27 | subcellular format | Scientific Literature | ||
8. | ALA3531183 | A | Drug level in human recombinant CYP3A4 treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Homo sapiens | 27 | single protein format | Scientific Literature | ||
9. | ALA3531185 | A | Drug level in human recombinant CYP3A5 treated with 10 uM 20(S)-ginsenoside Rh2 for 60 mins by MS2 spectra | Homo sapiens | 27 | single protein format | Scientific Literature |